Observational studyBMC pediatrics2026
Association between serum lysyl oxidase-like 2 and chitinase-3-like protein 1 levels and Mycobacterium tuberculosis drug resistance in children with pulmonary tuberculosis.
Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo investigate whether serum lysyl oxidase-like 2 (LOXL2) and chitinase-3-like protein 1 (YKL-40) levels are associated with drug-resistant Mycobacterium tuberculosis in children with pulmonary tuberculosis.
methodsIn this prospective observational study, 235 pediatric pulmonary tuberculosis patients treated at Hebei Provincial Chest Hospital from February 2021 to February 2025 were enrolled. Based on drug-susceptibility testing, participants were classified into a drug-resistant group (n = 63) and a drug-susceptible group (n = 172). Serum LOXL2 and YKL-40 concentrations were measured and correlated with resistance status. Multivariable logistic regression was used to identify independent risk factors for resistance. Receiver operating characteristic (ROC) curves assessed predictive performance, and a nomogram was constructed for further validation.
resultsSerum LOXL2 and YKL-40 levels were significantly higher in the drug-resistant group than in the drug-susceptible group (P < 0.05). Spearman correlation revealed a positive association between the two biomarkers (r = 0.433, P < 0.001). Multivariable analysis identified prior tuberculosis contact, elevated C-reactive protein, and increased LOXL2 and YKL-40 levels as independent predictors of drug resistance (P < 0.05). ROC analysis showed that combined LOXL2 and YKL-40 testing had good discriminatory ability (AUC = 0.912). The nomogram achieved AUCs of 0.945 in the training cohort and 0.802 in the validation cohort, with satisfactory calibration and Hosmer-Lemeshow goodness-of-fit.
conclusionsIn children diagnosed with tuberculosis, elevated serum levels of LOXL2 and YKL − 40 are significantly associated with drug resistance. These biomarkers may serve as potential predictors of drug resistance in children with confirmed tuberculosis, and their combined measurement can enhance the accuracy of risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.